Stem definition | Drug id | CAS RN |
---|---|---|
4390 | 4499-40-5 |
Molecule | Description |
---|---|
Synonyms:
|
|
Dose | Unit | Route |
---|---|---|
0.60 | g | O |
0.60 | g | R |
None
Date | Agency | Company | Orphan |
---|---|---|---|
Nov. 5, 1981 | FDA | WARNER CHILCOTT LLC |
None
None
None
None
Source | Code | Description |
---|---|---|
ATC | R03DA02 | RESPIRATORY SYSTEM DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES Xanthines |
ATC | R03DB02 | RESPIRATORY SYSTEM DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES Xanthines and adrenergics |
MeSH PA | D000963 | Antimetabolites |
MeSH PA | D002491 | Central Nervous System Agents |
MeSH PA | D005765 | Gastrointestinal Agents |
MeSH PA | D000960 | Hypolipidemic Agents |
MeSH PA | D057847 | Lipid Regulating Agents |
MeSH PA | D008082 | Lipotropic Agents |
MeSH PA | D018697 | Nootropic Agents |
MeSH PA | D018927 | Anti-Asthmatic Agents |
MeSH PA | D001993 | Bronchodilator Agents |
MeSH PA | D002317 | Cardiovascular Agents |
MeSH PA | D004791 | Enzyme Inhibitors |
MeSH PA | D018377 | Neurotransmitter Agents |
MeSH PA | D018373 | Peripheral Nervous System Agents |
MeSH PA | D010726 | Phosphodiesterase Inhibitors |
MeSH PA | D058914 | Purinergic Antagonists |
MeSH PA | D058915 | Purinergic P1 Receptor Antagonists |
MeSH PA | D019141 | Respiratory System Agents |
MeSH PA | D014665 | Vasodilator Agents |
CHEBI has role | CHEBI:25512 | neurotransmitters |
CHEBI has role | CHEBI:33284 | nutrients |
CHEBI has role | CHEBI:50904 | alergeno |
CHEBI has role | CHEBI:75771 | Mus musculus metabolites |
CHEBI has role | CHEBI:75772 | S. cerevisiae metabolites |
CHEBI has role | CHEBI:76924 | plant metabolites |
CHEBI has role | CHEBI:76971 | Escherichia coli metabolites |
CHEBI has role | CHEBI:77746 | Homo sapiens metabolite |
CHEBI has role | CHEBI:83056 | Daphnia magna metabolites |
CHEBI has role | CHEBI:35523 | bronchodilator |
CHEBI has role | CHEBI:35620 | vasodilator agents |
CHEBI has role | CHEBI:49103 | drug metabolites |
CHEBI has role | CHEBI:49167 | anti-asthmatic drugs |
CHEBI has role | CHEBI:50218 | phosphodiesterase inhibitors |
CHEBI has role | CHEBI:50846 | Immunologic factor |
CHEBI has role | CHEBI:51371 | muscle relaxants |
CHEBI has role | CHEBI:67079 | anti-inflammatory agents |
CHEBI has role | CHEBI:71232 | adenosine receptor antagonists |
CHEBI has role | CHEBI:76946 | fungal metabolites |
CHEBI has role | CHEBI:85234 | human blood serum metabolites |
None
None
None
None
None
None
Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
---|---|---|---|---|---|---|---|---|---|
Phosphodiesterase 4 | Enzyme | INHIBITOR | Ki | 4.25 | CHEMBL | CHEMBL | |||
Adenosine receptor A1 | GPCR | ANTAGONIST | Ki | 9.22 | CHEMBL | CHEMBL | |||
Adenosine receptor A2b | GPCR | ANTAGONIST | Ki | 5.57 | CHEMBL | CHEMBL | |||
Adenosine A2 receptor | GPCR | ANTAGONIST | Ki | 4.85 | CHEMBL | CHEMBL | |||
Phosphodiesterase 3 | Enzyme | INHIBITOR | CHEMBL | CHEMBL | |||||
Adenosine receptor A2a | GPCR | ANTAGONIST | Ki | 9.22 | CHEMBL | CHEMBL | |||
Adenosine receptor A3 | GPCR | ANTAGONIST | Ki | 7.85 | CHEMBL | ||||
Alkaline phosphatase, tissue-nonspecific isozyme | Enzyme | Ki | 4.09 | CHEMBL | |||||
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform | Kinase | IC50 | 4.12 | CHEMBL | |||||
Uncharacterized protein | Enzyme | Ki | 4.11 | CHEMBL | |||||
Adenosine receptor A3 | GPCR | Ki | 4.07 | CHEMBL | |||||
Adenosine receptor A1 | GPCR | Ki | 5.42 | CHEMBL | |||||
Adenosine receptor A1 | GPCR | Ki | 5.01 | CHEMBL | |||||
Adenosine A2 receptor | GPCR | Ki | 5.88 | CHEMBL | |||||
Adenosine A2b receptor | GPCR | Ki | 4.82 | CHEMBL | |||||
Adenosine receptor | GPCR | Ki | 4.70 | CHEMBL | |||||
Heart phosphodiesterase | Enzyme | IC50 | 4.04 | CHEMBL | |||||
Adenosine A2a receptor | GPCR | Ki | 4.89 | CHEMBL | |||||
Adenosine receptor A1 | GPCR | Ki | 6.15 | CHEMBL | |||||
Adenosine receptor A2a | GPCR | Ki | 5.17 | CHEMBL |
ID | Source |
---|---|
4018630 | VUID |
N0000179080 | NUI |
4017699 | VANDF |
4018129 | VANDF |
4018630 | VANDF |
C0055578 | UMLSCUI |
CHEBI:15354 | CHEBI |
CHEBI:28177 | CHEBI |
TEP | PDB_CHEM_ID |
CHEMBL1200434 | ChEMBL_ID |
DB01303 | DRUGBANK_ID |
656652 | PUBCHEM_CID |
10438 | RXNORM |
2086 | MMSL |
4173 | MMSL |
4436 | MMSL |
4875 | MMSL |
5213 | MMSL |
5563 | MMSL |
d00142 | MMSL |
d00756 | MMSL |
d03159 | MMSL |
000602 | NDDF |
000610 | NDDF |
002058 | NDDF |
111156002 | SNOMEDCT_US |
372810006 | SNOMEDCT_US |
387489007 | SNOMEDCT_US |
65123005 | SNOMEDCT_US |
66493003 | SNOMEDCT_US |
C0008405 | UMLSCUI |
C0039771 | UMLSCUI |
DB00122 | DRUGBANK_ID |
DB00277 | DRUGBANK_ID |
757 | INN_ID |
5967-84-0 | SECONDARY_CAS_RN |
D002794 | MESH_DESCRIPTOR_UI |
D013806 | MESH_DESCRIPTOR_UI |
305 | PUBCHEM_CID |
2153 | PUBCHEM_CID |
3K045XR58X | UNII |
None